Jul. 4 at 6:52 PM
$IBRX the vast majority of us here know the story, but there is a much vaster audience that has not heard the story. In the investment community there are many that see a company that is spending more than they make and a diminishing cash balance. It is just a matter of time before all that changes. Some time within the next year there will be more analyst coverage, more successful treatments, increasing revenues, broader awareness and acceptance of the science. Immunotherapy will be the new thing and we’ll be right in the center of it all. I’m perfectly content to hold through any upcoming bumps, because the story is going to become reality! I’ve been watching since inception and we are on the cusp of it all coming together. The good Doctor has been connecting dots for a long time!! And patience and patients are going to be rewarded! A treatment for lymphopenia - disruptive innovation in the extreme! Increasing longevity, seriously! Know what you own and sleep well. All the best!
